semaglutide sarcopenia GLP-1 Receptor Agonists for Obesity Management in Older Adults: A Scoping Review on the Risk of and Sarcopenic Obesity | Current Nutrition Reports Quit a GLP-1? Plan to

Whether you are in your 30s, 40s, or beyond, understanding how your body metabolizes estrogen can give you valuable insight into your long-term health

PEX-168 is a new agent of long-acting GLP-1R agonist, which is molecularly modified from EX via amino acid modification and PEGylation (119), the first GLP-1R agonist modified by PEG to achieve long-term pharmacological action (120, 121)

Optimize Body Weight : Weight loss achieved through semaglutide can improve ED over time by reducing strain on the cardiovascular system

Impact of Saccharomyces boulardii CNCM I-745 on Bacterial Overgrowth and Composition of Intestinal Microbiota in Diarrhea-Predominant Irritable Bowel Syndrome Patients: Results of a Randomized Pilot Study